LAC DPH Health Update: Revisions to Evusheld Dosing February 28, 2022 Key Messages The FDA has revised the emergency use authorization for Evusheld (tixagevimab plus cilgavimab) to increase the dose (from ... Read More
Statement from LACMA President Dr. Jeffery Lee Regarding LA Unified School District Announcement Mandating Vaccinations September 9, 2021 President of the Los Angeles County Medical Association, Jeffery Lee, MD The Los Angeles County Medical Association (LACMA) joins the ... Read More
Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19 August 27, 2021 Summary Ivermectin is a U.S. Food and Drug Administration (FDA)-approved prescription medication used to treat certain infections caused by internal ... Read More
CDPH Health Alert: Concerns re: the Use of Bamlanivimab Monotherapy in the Setting of SARS-CoV-2 Variants March 22, 2021 Bamlanivimab is an investigational monoclonal antibody product that received emergency use authorization (EUA) from the U.S. Food and Drug ... Read More